A Study of Brenipatide in Participants With Opioid Use Disorder
Conditions
Opioid Use Disorder
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
NoesisPharma - Phoenix - East Shea Boulevard, Phoenix, Arizona, United States
Contact: Principal Investigator (John Prater)Pillar Clinical Research- Little Rock, Little Rock, Arkansas, United States
Contact: Principal Investigator (Leslie Smith)Woodland International Research Group, Little Rock, Arkansas, United States
Contact: Principal Investigator (George Konis)Ark Clinical Research - Fountain Valley, Fountain Valley, California, United States
Contact: Principal Investigator (Justin Yanuck)Center on Substance Use and Health (CSUH), San Francisco, California, United States
Contact: Principal Investigator (Phillip Coffin)UCSF Weill Institute for Neurosciences - Substance Use Disorders Clinic - Mission Bay, San Francisco, California, United States
Contact: Principal Investigator (Khaled Moussawi)Bradenton Research Center, Inc., Bradenton, Florida, United States
Contact: Principal Investigator (Eric Folkens)K2 Medical Research - Daytona Beach, Daytona Beach, Florida, United States
Contact: Principal Investigator (Esteban Olivera)NextPhase Research Florida - Hollywood, Hollywood, Florida, United States
Contact: Principal Investigator (Peter Ventre)Accel Research Sites - Lakeland Clinical Research Unit, Lakeland, Florida, United States
Contact: Principal Investigator (James Andersen)Life Arc Research Centers - Miami, Miami, Florida, United States
Contact: Principal Investigator (Janny Rivera)Advanced Research for Health Improvement, LLC, Naples, Florida, United States
Contact: Principal Investigator (Leonard Lado)Innovative Research Institute - Port Charlotte, Port Charlotte, Florida, United States
Contact: Principal Investigator (Joseph Ravid)Better Years Ahead Medical Center, Tampa, Florida, United States
Contact: Principal Investigator (Ana Suarez)Neuroscience Research Institute - West Palm Beach, West Palm Beach, Florida, United States
Contact: Principal Investigator (Danesh Alam)Re:Cognition Health - Chicago, Chicago, Illinois, United States
Contact: Principal Investigator (Abid Nazeer)Indiana University Health Neuroscience Center, Indianapolis, Indiana, United States
Contact: Principal Investigator (Michael Bushey)University of Kentucky Chandler Medical Center, Lexington, Kentucky, United States
Contact: Principal Investigator (Shanna Babalonis)Maryland Treatment Centers - Mountain Manor Treatment Center, Baltimore, Maryland, United States
Contact: Principal Investigator (Marc Fishman)Maryland Treatment Centers - Avery Road Treatment Center, Rockville, Maryland, United States
Contact: Principal Investigator (Marc Fishman)Brigham and Women's Hospital, Boston, Massachusetts, United States
Contact: Principal Investigator (Joji Suzuki)Adams Clinical Boston, Boston, Massachusetts, United States
Contact: Principal Investigator (Darin Dougherty)Boston Medical Center, Boston, Massachusetts, United States
Contact: Principal Investigator (Alyssa Peterkin)Adams Clinical Watertown, Watertown, Massachusetts, United States
Contact: Principal Investigator (Daniel Rutrick)SKY Integrative Medical Center/SKYCRNG, Ridgeland, Mississippi, United States
Contact: Principal Investigator (Bob Hutchins)Adams Clinical Harlem, New York, New York, United States
Contact: Principal Investigator (Rachel Noone)Adams Clinical Bronx, The Bronx, New York, United States
Contact: Principal Investigator (Shama Farooq)Ohio Clinical Trials, Columbus, Ohio, United States
Contact: Principal Investigator (Angela Eakin)Rivus Wellness and Research Institute, Oklahoma City, Oklahoma, United States
Contact: Principal Investigator (Marvin Peyton)Adams Clinical Philadelphia, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Cassie Blanchard)Penn Medicine: University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Kyle Kampman)Brown University School of Public Health, Providence, Rhode Island, United States
Contact: Principal Investigator (Carolina Haass-Koffler)Avera Research Institute - Sioux Falls, Sioux Falls, South Dakota, United States
Contact: Principal Investigator (Vivek Anand)Adams Clinical Dallas, DeSoto, Texas, United States
Contact: Principal Investigator (Benji Kurian)Biopharma Informatic, LLC, Houston, Texas, United States
Contact: Principal Investigator (James Lai, MD)University of Virginia Health System, Charlottesville, Virginia, United States
Contact: Principal Investigator (Nassima Ait-Daoud Tiouririne)Carilion Clinic, Roanoke, Virginia, United States
Contact: Principal Investigator (Albert Arias)University of Washington - Harborview Medical Center, Seattle, Washington, United States
Contact: Principal Investigator (Elenore Bhatraju)CaRe Clinic, Calgary, Canada
Contact: Principal Investigator (Sumantra Ghosh)Med Trust Research, Courtice, Canada
Contact: Principal Investigator (Hamilton Jeyaraj)The Medical Arts Health Research Group, Kamloops, Canada
Contact: Principal Investigator (Dustin Janz)Kelowna Health and Memory Centre, Kelowna, Canada
Contact: Principal Investigator (Eugene Okorie)Providence Care, Kingston, Canada
Contact: Principal Investigator (Roumen Milev)Malton Medical Group, Mississauga, Canada
Contact: Principal Investigator (Brian Zidel)Comprehensive Treatment Clinic, Toronto, Canada
Contact: Principal Investigator (Leonard Bienenstock)Centre for Addiction and Mental Health (CAMH), Toronto, Canada
Contact: Principal Investigator (Bernard Le Foll)Research Works San Juan, Guaynabo, Puerto Rico
Contact: Principal Investigator (Jose Feliberti)Surrey and Borders Partnership NHS Foundation Trust, Chertsey, United Kingdom
Contact: Principal Investigator (CHRISTOS KOUIMTSIDIS)St Pancras Clinical Research - Eastbourne, Eastbourne, United Kingdom
Contact: Principal Investigator (Graham Campbell)Queen Elizabeth University Hospital, Glasgow, United Kingdom
Contact: Principal Investigator (Nagore Penades)St Pancras Clinical Research, London, United Kingdom
Contact: Principal Investigator (Ward Lawrence)Bioluminux - London, London, United Kingdom
Contact: Principal Investigator (Laxmi Patel)Lambeth Drug and Alcohol Treatment Consortium, London, United Kingdom
Contact: Principal Investigator (michael kelleher)Greater Manchester Mental Health NHS Foundation Trust, Manchester, United Kingdom
Contact: Principal Investigator (Stephen Kaar)Bioluminux Clinical Research - Milton Keynes, Milton Keynes, United Kingdom
Contact: Principal Investigator (Kayode Timothy)Bioluminux - Southampton, Southampton, United Kingdom
Contact: Principal Investigator (joshua asubiaro)Old Bank House Hillingdon Drug & Alcohol, Uxbridge, United Kingdom
Contact: Principal Investigator (Jeffrey Fehler)Bioluminux - Wolverhampton, Wolverhampton, United Kingdom
Contact: Principal Investigator (Joshua Olofinlade)
Study leads
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Study Director
Eli Lilly and Company